CTBO — Cantabio Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Cantabio Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2014 March 31st | R2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.087 | 0.078 | -0.751 | -1.11 | -2.01 |
| Non-Cash Items | — | -0.006 | -0.105 | 0.021 | 0.937 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.036 | -0.072 | 0.292 | 0.118 | 0.451 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.051 | 0 | -0.565 | -0.973 | -0.623 |
| Financing Cash Flow Items | 0.015 | 0 | 0.017 | 0.029 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.039 | 0 | 0.617 | 0.953 | 0.701 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.012 | 0 | 0.052 | -0.02 | 0.077 |